Dimethyl fumarate Polpharma Európska únia - slovenčina - EMA (European Medicines Agency)

dimethyl fumarate polpharma

zaklady farmafarmaceutyczne polpharma s.aceutyczne polpharma s.a. - dimetylfumarát - roztrúsená skleróza, recidivujúce-odosielajúcej - imunosupresíva - dimethyl fumarate polpharma is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.

Dimethyl fumarate Neuraxpharm Európska únia - slovenčina - EMA (European Medicines Agency)

dimethyl fumarate neuraxpharm

laboratorios lesvi s.l. - dimetylfumarát - roztrúsená skleróza, recidivujúce-odosielajúcej - imunosupresíva - dimethyl fumarate neuraxpharma is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.

Lutetium (177Lu) chloride Billev (previously Illuzyce) Európska únia - slovenčina - EMA (European Medicines Agency)

lutetium (177lu) chloride billev (previously illuzyce)

billev pharma aps - lutetium (177lu) chloride - radionuklidové zobrazovanie - terapeutické rádiofarmaká - lutetium (177lu) chloride billev is a radiopharmaceutical precursor, and it is not intended for direct use in patients. it is to be used only for the radiolabelling of carrier molecules that have been specifically developed and authorised for radiolabelling with lutetium (177lu) chloride.

Dimtruzic 240 mg Slovensko - slovenčina - ŠÚKL (Štátny ústav pre kontrolu liečiv)

dimtruzic 240 mg

sandoz pharmaceuticals d.d., slovinsko - dimetyl-fumarát - 59 - immunopraeparata

Dimtruzic 120 mg Slovensko - slovenčina - ŠÚKL (Štátny ústav pre kontrolu liečiv)

dimtruzic 120 mg

sandoz pharmaceuticals d.d., slovinsko - dimetyl-fumarát - 59 - immunopraeparata

Dimethyl fumarate Teva Európska únia - slovenčina - EMA (European Medicines Agency)

dimethyl fumarate teva

teva gmbh - dimetylfumarát - multiple sclerosis, relapsing-remitting; multiple sclerosis - imunosupresíva - dimethyl fumarate teva is indicated for the treatment of adult and paediatric patients aged 13 years and older with relapsing remitting multiple sclerosis (rrms).

Dimethyl fumarate Accord Európska únia - slovenčina - EMA (European Medicines Agency)

dimethyl fumarate accord

accord healthcare s.l.u. - dimetylfumarát - multiple sclerosis, relapsing-remitting; multiple sclerosis - imunosupresíva - dimethyl fumarate accord is indicated for the treatment of adult and paediatric patients aged 13 years and older with relapsing remitting multiple sclerosis (rrms).

Briumvi Európska únia - slovenčina - EMA (European Medicines Agency)

briumvi

neuraxpharm pharmaceuticals s.l. - ublituximab - multiple sclerosis, relapsing-remitting; multiple sclerosis - imunosupresíva - briumvi is indicated for the treatment of adult patients with relapsing forms of multiple sclerosis (rms) with active disease defined by clinical or imaging features.